Logo
Logo
Restricted. You are unable to purchase this product.
Generic

Co-Codamol 30/500mg Tablets

NPC021 (Pack 100)
Generic code: *CCC310

Trustpilot

Out of Stock
Out of StockSorry this product is currently out of stock and is expected in the next two weeks

Retail Price
£5.32

Out of Stock
Out of StockSorry this product is currently out of stock and is expected in the next two weeks

Product Overview

A powerful analgesic for the temporary management of acute, moderate pain. Co-codamol is a mix of codeine phosphate and paracetamol in a ratio of 30mg codeine, 500mg paracetamol. Co-codamol is often used in cases where a patient’s pain is not affected by other painkillers, and is particularly useful for managing toothaches, migraines, and neuralgia. These tablets cannot be used alongside additional paracetamol.

Features & Benefits:
  • Effective pain relief with a ~1 hour onset time.
  • Useful for pain management on a variety of conditions often seen by dental patients, such as toothache.
  • 100 tablets at 30/500mg strength, indicated for oral administration.
Product Details:
  • 100 30/500 mg Co-codamol tablets.
  • Each tablet contains: Paracetamol 500mg and Codeine Phosphate 30mg.
FAQs:
What is Co-codamol?

Co-codamol is a powerful analgesic, composed of a blend of paracetamol and codeine phosphate. This blend is 30mg codeine to 500mg paracetamol

How should I take Co-codamol?

These Co-codamol tablets are for oral administration and can be taken with or without food. Please see the patient information leaflet for more information.

Compound analgesic consisting of codeine phosphate and paracetamol.

Please refer to the information leaflet for instructions on use.

Please note packaging may differ to image.

Reviews

Generic

Co-Codamol 30/500mg Tablets

NPC021 (Pack 100)
Generic code: *CCC310

Trustpilot

Out of Stock
Out of StockSorry this product is currently out of stock and is expected in the next two weeks

Retail Price
£5.32

Out of Stock
Out of StockSorry this product is currently out of stock and is expected in the next two weeks